Household primary language was associated with vision screening, with children from non-English households exhibiting lower rates of pediatric vision screening.
This article was originally published by HCPLive®.
Children from households where English is not the primary language spoken are approximately 20% less likely to undergo recommended vision screening compared with children from households where English is the primary language, according to findings from a recent study.1
Results suggested differences in access to care by household language, with children from English-speaking households more likely to receive vision screening at school or from an ophthalmologist than children from non-English-speaking households.
“An estimated 12 million children in the US speak a language other than English at home. Previous studies demonstrate children whose families required a translator were less likely to seek pediatric ophthalmology care,” wrote Anne Kim, of the department of ophthalmology at Rush University Medical College, and colleagues.
The American Academy of Pediatrics recommends vision screening as a routine part of every primary care visit, including physical examination with inspection, red reflex evaluation, corneal light reflection, and cover-uncover test from birth, and formal chart-based acuity testing from 3 years of age on. Vision screening results may uncover health issues requiring a comprehensive eye exam, which could lead to earlier treatment and prevention if caught at a young age. Thus, understanding barriers to pediatric vision screening is important for providing affected patient populations with the proper resources and care.2,3
Investigators sought to determine and compare rates of vision screening among children from non-English and English primary language households, further examining the setting and locations of vision screening. To do so, data was collected for children 3-17 years of age enrolled in the 2018-2020 National Survey of Children’s Health.1
The primary outcome of interest was vision screening within the past 12 months, measured through parent responses to the question “During the past 12 months, has this child had his or her vision tested, such as with pictures, shapes, or letters?” Parents were also asked about the setting in which the vision screening was performed.
A total of 89,697 children enrolled in the 2018-2020 National Survey of Children’s Health were included in the present study. Among the cohort, 51.1% of participants were male, 49.9% were White, and 14.6% were from non-English primary language households. A total of 64,441 (70.9%) children received vision screening in the previous 12 months.
In multivariable logistic regression models adjusted for age, gender, race, parental education, income, insurance coverage, and geographic location, children from households where English was not the primary language had lower rates of vision screening compared with their English primary language counterparts (64.3% vs 72.0%; adjusted OR [aOR], 0.83; 95% CI, 0.72-0.95).
Further analysis revealed children from households where English was not the primary language were more likely to receive vision screening at a health clinic compared with children from English primary language households (14.4% vs 3.1%; aOR, 3.25; 95% CI, 2.40-4.39; P < .0001). Investigators noted children from English-speaking households were more likely to receive vision screening at school (21.0% vs 16.1%; aOR, 0.72; 95% CI, 0.57-0.89; P = .003) and from an ophthalmologist (54.0% vs 49.0%; aOR, 0.72; 95% CI, 0.61-0.85; P = .0001). However, there were no differences in rates of screening by a physician (41.4% for non-English primary language vs 44.0% for English primary language; aOR, 1.05; 95% CI, 0.89-1.23; P = .60).
“Differences in vision screening by household language were driven by lower rates of screening by an ophthalmologist or optometrist and at schools. These findings suggest unequal access to care by household language and provide actionable data to inform policies and patient care,” investigators concluded.
References
1. Kim AB, Cheng BT. Socioeconomic Disparities in Vision Screening Among United States Children. Paper Presented at: American Academy of Ophthalmology 2023. November 3-6, 2023.
2. Adam, H. Vision screening. Point-of-care quick reference. April 2, 2020. Accessed November 16, 2023. https://publications.aap.org/pediatriccare/article-abstract/doi/10.1542/aap.ppcqr.396022/127/Vision-Screening
3. Gugdel, D. Eye screening for children. tips & prevention. March 23, 2021. Accessed November 16, 2023. https://www.aao.org/eye-health/tips-prevention/children-eye-screening
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Cost Savings From an mHealth Tool for Improving Medication Adherence
October 21st 2024The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.
Read More
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More